TITLE

Stereotactic radiosurgery for patients with recurrent intracranial ependymomas

AUTHOR(S)
Stauder, Michael; NI Laack, Nadia; Ahmed, Kamran; Link, Michael; Schomberg, Paula; Pollock, Bruce
PUB. DATE
July 2012
SOURCE
Journal of Neuro-Oncology;Jul2012, Vol. 108 Issue 3, p507
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The objective of the study is to define the tumor control rate and complications associated with stereotactic radiosurgery (SRS) for patients with recurrent intracranial ependymoma. Retrospective review of 26 patients (49 tumors) having SRS between 1990 and 2008. Twenty-five patients (96 %) had undergone one or more craniotomies; one patient underwent SRS for a metastatic tumor after resection of a spinal ependymoma. Nineteen patients (73 %) had received cranial external beam radiotherapy (median dose, 54 Gy). Eight patients (31 %) were less than 18 years old. The median target volume was 2.2 cm (range, 0.3-66.6); the median tumor margin dose was 18 Gy (range, 12-24). The median follow-up after SRS was 3.1 years (range, 3 months-13.1 years). The median overall survival after SRS was 5.5 years. The 1-year and 3-year survival rates were 96 and 69 %, respectively. Local tumor control (LC) was achieved in 33 of 49 lesions (67 %) with a median time to progression of 14.7 months (range, 2.9 months-11.2 years). The 1-year and 3-year progression-free survival rates were 80 and 66 %, respectively. The 1-year and 3-year LC rate was 85 and 72 %, respectively. On univariate analysis, higher tumor grade was associated with worse OS (grade 3-4, 27 % vs grade 2, 82 %, p = 0.04). Seven patients (27 %) had distant tumor progression and two patients (8 %) had symptomatic radiation necrosis after SRS. SRS for recurrent intracranial ependymoma provided good LC and may improve survival for patients with limited recurrent disease after prior treatment.
ACCESSION #
76350885

 

Related Articles

  • Surgical navigation for meningioma surgery. Omay, S. Bulent; Barnett, Gene H. // Journal of Neuro-Oncology;Oct2010, Vol. 99 Issue 3, p357 

    The use of surgical navigation systems (SNSs) is well established in intracranial surgery for gliomas and metastases yet some doubt its benefit in surgery for intracranial meningiomas. In this chapter we review the authors' experiences and literature on how use of surgical navigation may be...

  • Towards improving the safety and diagnostic yield of stereotactic biopsy in a single centre. Dammers, Ruben; Schouten, Joost W.; Haitsma, Iain K.; Vincent, Arnaud J. P. E.; Kros, Johan M.; Dirven, Clemens M. F. // Acta Neurochirurgica;Nov2010, Vol. 152 Issue 11, p1915 

    Background: Previously, we reported on our single centre results regarding the diagnostic yield of stereotactic needle biopsies of brain lesions. The yield then (1996-2006) was 89.4%. In the present study, we review and evaluate our experience with intraoperative frozen-section histopathologic...

  • Stereotactic radiosurgery for intracranial chondrosarcoma. Iyer, Aditya; Kano, Hideyuki; Kondziolka, Douglas; Liu, Xiaomin; Niranjan, Ajay; Flickinger, John; Lunsford, L. // Journal of Neuro-Oncology;Jul2012, Vol. 108 Issue 3, p535 

    To assess outcomes after stereotactic radiosurgery (SRS) for chondrosarcomas of the skull base, we reviewed 22 patients with cranial base chondrosarcomas who underwent SRS between 1987 and 2009. The median patient age was 42 years (range, 15-75). The median SRS target volume was 8.0 cc (range,...

  • Incidence and Risk Factors or Early Postoperative Seizure in Patients with Intracranial Tumor Removal: Prasat Neurological Institute Experience. Kullapat Veerasarn; Paveen Tadadontip // Thai Journal of Surgery;Oct-Dec2011, Vol. 32 Issue 4, p124 

    Objectives: To evaluate the incidence and to identify the risk factors of early postoperative seizure (POSz) (within one week after surgery) in patients underwent intracranial tumor removal. Methods: Medical records of patients who had their brain tumor removed during June 2006 - May 2007 were...

  • SBRT schedule not linked to poorer local control in spinal metastases.  // Hem/Onc Today;11/10/2011, Vol. 12 Issue 21, p34 

    The article reports that a 2-year study at the Mayo Clinic has found that one- and two-year overall survival (OS) rates were similar for patients with spinal metastases who underwent multifractional stereotactic body radiation therapy compared with those who underwent single daily fractions.

  • Characterisation of dose distribution in linear accelerator-based intracranial stereotactic radiosurgery with the dynamic conformal arc technique: consideration of the optimal method for dose prescription and evaluation. Ohtakara, K.; Hayashi, S.; Hoshi, H. // British Journal of Radiology;Jan2012, Vol. 85 Issue 1009, p69 

    Objectives: The purpose of this study was to characterise dose distribution in linear accelerator-based intracranial stereotactic radiosurgery using the dynamic conformal arc technique, and to validate the pertinence of dose prescription to the specific percentage isodose surface (IDS). Methods:...

  • Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Kim, J. E.; Kim, D. G.; Paek, S. H.; Jung, H.-W. // Acta Neurochirurgica;Jul2003, Vol. 145 Issue 7, p547 

    Background. The authors present a retrospective analysis of 308 computed tomography (CT)-guided stereotactic biopsies in 300 patients in order to evaluate the reliability and efficacy of the stereotactic biopsy for intracranial lesions. Method. All patients were suffering from undetermined...

  • Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Grossman, R.; Sadetzki, S.; Spiegelmann, R.; Ram, Z. // Acta Neurochirurgica;Jun2005, Vol. 147 Issue 6, p627 

    Object. Stereotactic brain biopsy is a routinely used technique for the diagnosis of brain lesions. Due to its minimally invasive nature, the potential risks associated with this procedure are sometimes underestimated. We have retrospectively analyzed the incidence of symptomatic and...

  • Robotic stereotactic body radiation therapy for liver-limited malignant tumors. Frączek, Mariusz; Sobocki, Jacek; Pędziwiatr, Katarzyna; Skrocki, Edward; Piotrkowicz, Norbert; Tyc-Szczepaniak, Dobromira; Korab-Chrzanowska, Elżbieta; Hevelke, Piotr; Krasnodębski, Maciej; Koszewski, Waldemar // Videosurgery & Other Miniinvasive Techniques / Wideochirurgia i;Dec2014, Vol. 9 Issue 4, p511 

    Introduction: Stereotactic body radiotherapy (SBRT) is rapidly gaining favor as a new treatment modality for malignant liver tumors. Most of the studies have recruited patients with disseminated disease originating from the liver. This study focuses on disease limited to the liver. Aim: To...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics